Bioequivalence and Bioavailability Forum

24 matches found.

• Probability to pass multiple studies ? Helmut 2022-06-24 16:03 [Power / Sample Size]
• CI inclusion ≠ TOST Helmut 2020-12-04 21:30 [BE/BA News]
• Οὐτοπεία ∨ Εὐτοπεία Helmut 2020-12-02 02:37 [RSABE / ABEL]
• BABE 101 (lenghty and spiced with PK) Helmut 2020-07-23 18:02 [Software]
• RSABE ≠ ABE: Simulations mandatory Helmut 2020-06-11 14:26 [Power / Sample Size]
• Inflation of the TIE as well zizou 2020-02-01 18:00 [RSABE / ABEL]
• Inflation of the TIE as well Helmut 2020-01-29 16:38 [RSABE / ABEL]
• Books & intersection-union Helmut 2019-11-19 13:01 [General Sta­tis­tics]
• I'm seeking to understand the math behind our current regulation victor 2019-11-17 11:53 [General Sta­tis­tics]
• What do you want to achieve? Helmut 2019-11-17 02:26 [General Sta­tis­tics]
• TIE = chance of passing at the border(s) Helmut 2019-11-08 21:26 [RSABE / ABEL]
• Inflation type one error PharmCat 2019-11-08 19:15 [RSABE / ABEL]
• ’Some’ should read the GL (and again, and again) Helmut 2019-07-27 15:48 [Study As­sess­ment]
• TIE = p(BE) at expanded limits Helmut 2017-04-28 21:16 [RSABE / ABEL]
• GMR, theta 0 and that all d_labes 2017-03-09 10:21 [Two-Stage / GS Designs]
• Hypotheses in non-inferiority trials mittyri 2015-06-16 23:52 [Power / Sample Size]
• Ad hoc power The Outlaw Torn 2015-06-15 13:20 [Power / Sample Size]
• Hypotheses in Bioequivalence Studies Helmut 2013-06-21 15:51 [General Sta­tis­tics]
• Null hypothesis, PowerTOST/sampleN.inf() ElMaestro 2012-10-07 15:11 [BE/BA News]
• Null hypothesis, PowerTOST/sampleN.inf() Helmut 2012-10-06 03:14 [BE/BA News]
• Patient’s risk = 5% Helmut 2012-02-13 13:41 [General Sta­tis­tics]
• HVDs/HVDPs parallel add on design? Helmut 2011-10-11 16:34 [Design Issues]
• two stage design Helmut 2011-08-22 19:35 [Two-Stage / GS Designs]
• Significance, power, hypotheses - what does it all mean d_labes 2008-11-21 10:34 [Regulatives / Guidelines]